Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Brain Sciences|March 6, 2021
Long-Lasting Cognitive Abnormalities after COVID-19Roberta Ferrucci, Michelangelo Dini, Elisabetta Groppo, et al.
Patient Preference and Adherence|June 3, 2010
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjectsMonica Airoldi, Mauro Zaccarelli, Luca Bisi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 17, 2013
CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patientsGiovanni Guaraldi, Kety Luzi, Giusi Maria Bellistrì, et al.
AIDS (London, England)|December 12, 2018
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?Mattia Trunfio, Carmela Pinnetti, Emanuele Focà, et al.
AIDS (London, England)|May 5, 2024
Association between tight junction proteins and cognitive performance in untreated persons with HIVFrancesca Bai, Valeria Bono, Lidia Borghi, et al.
AIDS (London, England)|October 1, 2019
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performancesGiuseppe Lapadula, Davide Paolo Bernasconi, Francesca Bai, et al.
HIV Medicine|December 17, 2023
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effectsAlice Ranzani, Francesco Castelli, Antonio Di Biagio, et al.
Pageof 6